Cost-Effectiveness of Recombinant Human Erythropoietin for Reducing Red Blood Cells Transfusions in Critically Ill Patients
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Value in Health
- Vol. 8 (2) , 105-116
- https://doi.org/10.1111/j.1524-4733.2005.04006.x
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*Critical Care Medicine, 2004
- Anemia and Blood Transfusion in Critically Ill PatientsJAMA, 2002
- Anemia of the critically ill: “Acute” anemia of chronic diseaseCritical Care Medicine, 2000
- Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patientsCritical Care Medicine, 1999
- Transfusion Medicine — Blood TransfusionNew England Journal of Medicine, 1999
- Guidelines for Red Blood Cells and Plasma Transfusion for Adults and Children: An Emergency Physician's Overview of the 1997 Canadian Blood Transfusion GuidelinesThe Journal of Emergency Medicine, 1998
- Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group.American Journal of Respiratory and Critical Care Medicine, 1997
- RBC Transfusion in the ICUChest, 1995
- Practice Strategies for Elective Red Blood Cell TransfusionAnnals of Internal Medicine, 1992
- Perioperative Red Blood Cell TransfusionPublished by American Medical Association (AMA) ,1988